E Fund Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.6K Sell
11,589
-3,954
-25% -$14.4K ﹤0.01% 488
2026
Q1
$61.4K Buy
+15,543
New +$78.3K ﹤0.01% 485
2024
Q2
Sell
-13,622
Closed -$105K 350
2024
Q1
$105K Buy
+13,622
New +$109K 0.01% 364
2023
Q4
Sell
-11,535
Closed -$84K 320
2023
Q3
$84K Buy
+11,535
New +$85.9K 0.01% 287
2022
Q4
Sell
-11,207
Closed -$32K 347
2022
Q3
$32K Sell
11,207
-787
-7% -$2.8K ﹤0.01% 332
2022
Q2
$42K Buy
11,994
+1,321
+12% +$5.17K ﹤0.01% 322
2022
Q1
$50K Buy
+10,673
New +$52.2K ﹤0.01% 323

Other funds holding MDXG

E Fund Management's MDXG Position: Q2 2026 in Review

E Fund Management reduced its MiMedx Group (MDXG) stake by 25% in Q2 2026, selling an estimated $14.4K and leaving 11,589 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

E Fund Management first reported a position in MDXG in Q1 2022 and has held it in 7 quarters since. The position peaked at $105K in Q1 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • E Fund Management held 11,589 shares of MiMedx Group worth $44.6K as of Q2 2026.
  • E Fund Management sold 3,954 MiMedx Group shares in Q2 2026, an estimated $14.4K.
  • MiMedx Group made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #488 holding.
  • E Fund Management first reported a position in MiMedx Group in Q1 2022 and has held it in 7 quarters since.
  • E Fund Management's MiMedx Group position peaked at $105K in Q1 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.